期刊文献+

健康体检人群中抗核抗体的年龄及性别分布状况研究 被引量:6

Effect of age and gender on distribution of antinuclear antibodies in healthy population
下载PDF
导出
摘要 目的探讨健康人群的年龄与性别对抗核抗体(ANA)表达的影响。方法选取2013年6月至2014年6月在我院行常规体检的健康人群1 167例,受试者知情下空腹采血间接免疫荧光法检测ANA表达,以滴度≥1:100为阳性。分析ANA在健康人群中的年龄及性别分布状况。年龄及性别与ANA阳性率的相关性采用Spearman分析。结果 1 167例健康受试者中ANA阳性者157例,阳性率为13.45%。随着年龄增长,ANA阳性率在健康人群中有明显增大的趋势;而在同一年龄区间,女性的阳性率明显大于男性(P<0.05)。Spearman分析显示,年龄与健康人群ANA阳性率呈正相关性(rs=0.310,P<0.05);性别与健康人群ANA阳性率呈正相关性(rs=0.608,P<0.01)。结论抗核抗体在健康人群中表达会受年龄和性别因素影响。 Objective To explore the effect of age and gender on distribution of antinuclear antibodies(ANA) in healthy population.Methods A total of 1 167 healthy people who had routine check-up between June2013 and June 2014 in our hospital were selected.The informed participants were taken fasting blood samples to determine ANA expression by indirect immunofluorescence assay(IFA).Titer≥1:100 was set as positive result.The effect of age and gender on distribution of antinuclear antibodies(ANA) in the healthy population were analyzed.The correlations between ANA positive and age or gender were analyzed by Spearman method.Results Among 1 167 participants,157 showed ANA positive and the positive rate of ANA was 13.45%.There was a significantly increased trend of ANA positive rate with age within the healthy population.The positive rate of female participants was apparently higher than that of male participants in the same age range(P〈0.05).Spearman analysis showed that there was a positive correlation between ANA positive rate and age(rs=0.310,P=0.037),and also between ANA positive rate and gender(rs=0.608,P〈0.001).Conclusion Age and gender would affect the expression of ANA in the healthy population.
作者 钱培新 王蕾
出处 《海南医学》 CAS 2015年第2期201-203,共3页 Hainan Medical Journal
关键词 抗核抗体 健康人群 年龄 性别 相关性分析 Antinuclear antibodies Healthy population Age Gender Correlation analysis
  • 相关文献

参考文献14

  • 1Abeles AM, Abeles M. The clinical utility of a positive antinuclearantibody test result [J]. The American Journal of Medicine, 2013,126(4): 342-348.
  • 2Mahler M, Dervieux T. Comments on recent advances and recom-mendations for the assessment of autoantibodies to cellular antigensreferred as antinuclear antibodies [J]. Annals of The Rheumatic Dis-eases, 2014, 73(7): 36.
  • 3Bossuyt X, Cooreman S, De Baere H, et al. Detection of antinuclearantibodies by automated indirect immimofluoresccnce analysis [J].ClinicaChimicaActa, 2013,415: 101-106.
  • 4Pisetsky DS. Antinuclear antibodies in rheumatic disease: A propos-al for a fiinction-based classification [J]. Scandinavian Journal ofImmunology, 2012, 76(3): 223-228.
  • 5孙家祥,李艳.652例抗核抗体阴性病例的抗核抗体谱的检测分析[J].海南医学,2011,22(7):113-114. 被引量:12
  • 6Arbuckle MR, James JA, Kohlhase KF, et al. Development of an-ti-dsDNA autoantibodies prior to clinical diagnosis of systemic lu-pus erythematosus [J]. Scand J Immunol, 2001, 54(1-2): 211-219.
  • 7Avouac J, Gossec L, Dougados M. Diagnostic and predictive valueof anti-cyclic citrullinated protein antibodies in rheumatoid arthritis:a systematic literature review [J]. Annals of the Rheumatic Diseas-es, 2006,65(7): 845-851.
  • 8Satoh M, Chan EKL, Ho LA, et al. Prevalence and sociodemograph-ic correlates of antinuclear antibodies in the United States [J]. Ar-thritis & Rheumatism, 2012, 64(7): 2319-2327.
  • 9Sakaguchi S, Powrie F, Ransohofif RM. Re-establishing immunolog-ical self-tolerance in autoimmune disease [J]. Nature Medicine,2012,18(1): 54-58.
  • 10徐婧,张卓莉.环磷酰胺治疗自身免疫疾病中的不良反应及防治[J].中华临床医师杂志(电子版),2012,6(15):143-144. 被引量:28

二级参考文献50

  • 1徐新云.NOS抑制剂对环磷酰胺致出血性膀胱炎的保护作用[J].毒理学杂志,2005,19(A03):255-255. 被引量:1
  • 2胡朝军,李永哲,佟大伟,张蜀澜.临床14 282份标本自身抗体谱检测结果分析[J].中华检验医学杂志,2006,29(8):688-691. 被引量:19
  • 3李永哲.自身抗体检测技术临床推广应用和质量保证工作中应重视的问题[J].中华检验医学杂志,2006,29(9):769-773. 被引量:81
  • 4龙振洲.医学免疫学[M].北京:人民卫生出版社,1998.43-49.
  • 5SCHEINFELD N. Adalimumab(HUMIRA): a review[J]. J Drugs Dermatol, 2003, 2(4): 375-377.
  • 6WEINBLATT ME, KEYSTONE EC, FURST DE, et al. Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial[J]. Arthritis Rheum, 2003, 48(1 ) : 35-45.
  • 7WEINBLATT ME, KEYSTONE EC, FURST DE, et al. Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended study[J]. Ann Rheum Dis, 2006, 65(6) : 753-759.
  • 8van de PUTTE LB, ATKINS C, MALAISE M, et al. Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed [J]. Ann Rheum Dis, 2004, 63(5): 508-516.
  • 9KEYSTONE EC, KAVANAUGH AF, SHARP JT, et al. Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody)in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebocontrolled, 52-week trial[J]. Arthritis Rheum, 2004, 50(5): 1400-1411.
  • 10FURST DE, SCHIFF MH, FLEISCHMANN RM, et al. Adatinmmab, a fully human antitumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment rheumatoid arthritis: results of STAR (safety trial of adalimumab in rheumatoid arthritis)[J]. J Rheumatol, 2003, 30(12): 2563-2571.

共引文献74

同被引文献58

  • 1World Health Organization :Report of the Meeting on the Prevention of Infertility at the Primary Health Care Level. WHO[M]. Geneva, WHO/MCH/1984.4, 1983.
  • 2Stephen EH, Chandra A. Updated projections of infertility in the United States : 1995-2025 [J].Fertil Steril, 1998,70 : 30e4.
  • 3Check JH, Katsoff B, Wilson C, et al. Pregnancy outcome following fresh vs frozen embryo transfer into gestational carders using a simplified slow freeze protocol[J].Clin Exp Obstet Gynecol, 2012, 39 (1) :23-4.
  • 4Guleria I, Sayegh MH. Maternal acceptance of the fetus :true human tolerance[J].J Immunol, 2007, 178:3345-3351.
  • 5Kjersti M, Aagaard-Tillery KM, Silver R, et al. Immunology of normal pregnancy[J].Semin Fetal Neonatal Med, 2006, 11 : 279-295.
  • 6Dias JA Jr, de Oliveira RM, Abrao MS. Antinuclear antibodies and endometriosis[J].Int J Gynaecol Obstet, 2006, 93:262-263.
  • 7Ticconi C, Rotondi F, Veglia M, et al. Antinuclear autoantibodies in women with recurrent pregnancy loss[J].Am J Reprod Immunol, 2010,64:384-392.
  • 8Ying Y, Zhong YP, Zhou CQ, et al. Antinuclear antibodies predicts a poor IVF-ET outcome :impaired Egg and embryo development and reduced pregnancy rate[J].Immunol Invest, 2012,41:458-468.
  • 9Peng X, Tang J, WaY, et al. Novel method for ANA quantitation using IIF imaging system[J].J Immunol Methods, 2014,404:52-8.
  • 10Ying Ying, Yi-Ping Zhong, Can-Q uan Zhou, et al. A Further Exploration of the Impact of Antinuclear Antibodies on In Vitro Fertilization Embryo Transfer Outcome[J].Am J Reprod Immunol, 2013, 70:221-229.

引证文献6

二级引证文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部